NNHPD Performance Standards
PRODUCT LICENSING: There are approximately 3980 files in Class III (3712 in June) (this includes new and post-licensing files that are in queue and working), of those approximately […]
Advocacy & Action
CA Supports the Remission of Tariffs on Certain “Essential” Personal Care Products
We understand that some CA members are considering submitting a request for the remission of tariffs on certain self-care products considered to be non-discretionary purchases and essential to Canadians’ health […]
ICCS 2024 Annual Report
The International Collaboration on Cosmetics Safety (ICCS) published its annual report for 2024. ICCS is a global initiative, based in New York, focused on advancing the adoption of animal-free safety assessment of […]
New Homosalate Restrictions in Europe
Homosalate is a UV filter permitted for use in cosmetic products. Based on the opinion from the Scientific Committee on Consumer Safety (SCCS) in the European Union in 2021, the maximum concentration […]
IFRA Information Letter 1208
The 23rd ATP to the EU CLP regulation, (COMMISSION DELEGATED REGULATION (EU) 2025/1222) was published on June 20, 2025, in the Official Journal of the European Union (see Attachment […]
Guide to Reporting to the Federal Plastics Registry – Phase 2
Please see below the proposed summary of Phase 2 Guidance for the Federal Plastics Registry in both English and French. The government is seeking input on these documents […]
Upcoming Publication of How to Demonstrate Foreign Building Compliance with Drug GMPs GUI-0080
Health Canada has finally updated its guidance document, How to demonstrate foreign building compliance with drug good manufacturing practices: GUI-0080, to improve predictability and transparency for the drug industry. […]
Consultation on the Revised NHP Management of Applications Policy
The NNHPD is consulting on this guidance document in two phases: Wave 1 (current): administrative changes and process improvements, while reflecting the current state of application management, […]
NHP Labelling Engagement – Update and Next Session
The Natural and Non-prescription Health Products Directorate (NNHPD) is actively working on updating natural health product (NHP) labeling. The NNHPD is planning another engagement session for September. This […]
Health Product Safety Summary – 2024 Adverse Reaction Data
The Marketed Health Products Directorate published its 2024 adverse reactions (ARs) reporting through the Canada Vigilance Program (CVP). CVP collects reports of suspected adverse ARs to health products, including […]
